Several antibiotic-resistant gonorrhoea cases detected in UK  

Several antibiotic-resistant gonorrhoea cases detected in UK  
Bacteria Neisseria gonorrhoeae, gonoccoccus, diplococci which cause sexually transmitted infection gonorrhoea. 3D illustration

Three new cases of antibiotic-resistant gonorrhoea have been reported by the UK Health Security Agency. 

The first case of the sexually transmitted infection – otherwise known as super-gonorrhoea – was reported in the UK in 2016. Since then, several cases of the STI have been detected in the UK, including at least three cases3 in 2022. 

According to the UKHSA, a woman in her 20s from London and a heterosexual couple in their 20s from the Midlands have recently been diagnosed with a strain of the STI that could not be treated with the first-line antibiotic ceftriaxone. 

The recent cases have sparked ‘further public health investigations,’ the UKHSA said yesterday.  

Dr Katy Sinka, STI section head at the UKHSA, said it was ‘too soon to say’ whether gonorrhoea resistant to this ceftriaxone was spreading in the country. 

Related Article: Defect notice issued for Olmesartan medoxomil tablets due to PIL error

However, she said that STIs are on the rise ‘in general’. 

‘After a couple of years without any cases of this hard-to-treat form of gonorrhoea, we have now seen 4 cases in the last 2 months,’ she added.  

According to WHO, 82 million new cases of gonorrhoea occurred in 2020. 

Although the infection is not life-threatening, it can lead to infertility in both men and women and other complications including pelvic inflammatory disease.  

The financial costs of complications that arise from the infection are ‘very high’ for both individuals and health care systems, WHO explained.  

What are the symptoms of gonorrhoea?

In women, symptoms can include: 

  • pain Pain or a burning sensation when passing urine 
  • Aan unusual vaginal discharge, which may be thin or watery and green or yellow in colour 
  • pain Pain or tenderness in the lower abdominal area (this is less common) 
  • bleeding Bleeding between periods, heavier periods and bleeding after sex (this is less common). 

In men, symptoms can include: 

  • Ppain or a burning sensation when urinating 
  • Aan unusual discharge from the tip of the penis, which may be white, yellow or green 
  • Iinflammation (swelling) of the foreskin 
  • pain Pain or tenderness in the testicles (this is rare). 

Infection in the rectum, throat or eyes:  

Both men and women can develop an infection in the rectum, throat or eyes by having unprotected anal or oral sex. 

Related Article: Alert issued over TB treatment drug shortages

If infected semen or vaginal fluid comes into contact with the eyes, you can also develop conjunctivitis. 

Infection in the rectum can cause discomfort, pain or discharge. Infection in the eyes can cause irritation, pain, swelling and discharge, and infection in the throat usually causes no symptoms 

Source: NHS 

Last month, health officials warned of the rise of another ‘extremely antibiotic-resistant’ STI, shigella, in the UK, which if left untreated can be life-threatening. 

The UKHSA said 47 cases of shigella had been reported in the four-month period between September 2021 and January 2022, compared with 16 cases in the previous 17 months (April 2020 to August 2021). 

UKHSA has been following the strain since 2018, but recent cases showed that resistance is increasing. 

Related Article: GPhC chief executive and registrar to step down from role

This comes as antimicrobial resistance is reportedly the leading cause of death worldwide. A study in The Lancet, published last week, found that antimicrobial resistance kills about 3,500 people every day worldwide. 

In September, The Pharmacist reported the number of sexually-transmitted infections (STIs) diagnosed across England was down by almost a third in 2020, compared to the previous year. 

UKSHA attributed the fall in diagnoses to disruption to sexual health testing services. 

Want news like this straight to your inbox?
Sign up for our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.